Abstract:Medication access is critical to achieving optimal patient outcomes. The 2020 Task Force on Medication Access was charged with developing an ACCP white paper on improving medication access that addresses barriers such as cost, health disparities, and utilization management practices. This white paper outlines major barriers to medication access and provides pharmacists and professional organizations with policy and practice recommendations to help reduce barriers, enhance medication access, and fulfill the goa… Show more
“…6 Pharmacists have long been aware of challenges that patients often face in accessing prescription medications, including medication cost, lack of or limited insurance coverage, or distance from a pharmacy. 7 Pharmacists are trained in providing direct patient care for people living with chronic conditions, including psychiatric disorders, by identifying and resolving medication therapy problems (MTPs). 8 With more pharmacists practicing in team-based medical practices, additional SDOH that impact or intersect with optimal medication use, beyond access to medications, have emerged.…”
Introduction:
Social determinants of health (SDOH) affect outcomes of people living with psychiatric disorders, including substance use disorders. As experts in medication optimization, pharmacists play a vital role in identifying and addressing medication-related problems associated with SDOH. However, there is a paucity of literature on how pharmacists can be part of the solution.
Objective:
The purpose of this article is to provide a narrative review and commentary on the intersection between SDOH, medication-related outcomes in people living with psychiatric disorders, and the role of pharmacists in addressing them.
Method:
The American Association of Psychiatric Pharmacists appointed an expert panel to research the issue, identify barriers, and develop a framework for including pharmacists in addressing medication therapy problems associated with SDOH in people with psychiatric disorders. The panel used Healthy People 2030 as the framework and sought input from public health officials to propose solutions for their commentary.
Results:
We identified potential connections between SDOH and their impact on medication use in people with psychiatric disorders. We provide examples of how comprehensive medication management can afford opportunities for pharmacists to mitigate medication-related problems associated with SDOH.
Conclusion:
Public health officials should be aware of the vital role that pharmacists play in addressing medication therapy problems associated with SDOH to improve health outcomes and to incorporate them in health promotion programs.
“…6 Pharmacists have long been aware of challenges that patients often face in accessing prescription medications, including medication cost, lack of or limited insurance coverage, or distance from a pharmacy. 7 Pharmacists are trained in providing direct patient care for people living with chronic conditions, including psychiatric disorders, by identifying and resolving medication therapy problems (MTPs). 8 With more pharmacists practicing in team-based medical practices, additional SDOH that impact or intersect with optimal medication use, beyond access to medications, have emerged.…”
Introduction:
Social determinants of health (SDOH) affect outcomes of people living with psychiatric disorders, including substance use disorders. As experts in medication optimization, pharmacists play a vital role in identifying and addressing medication-related problems associated with SDOH. However, there is a paucity of literature on how pharmacists can be part of the solution.
Objective:
The purpose of this article is to provide a narrative review and commentary on the intersection between SDOH, medication-related outcomes in people living with psychiatric disorders, and the role of pharmacists in addressing them.
Method:
The American Association of Psychiatric Pharmacists appointed an expert panel to research the issue, identify barriers, and develop a framework for including pharmacists in addressing medication therapy problems associated with SDOH in people with psychiatric disorders. The panel used Healthy People 2030 as the framework and sought input from public health officials to propose solutions for their commentary.
Results:
We identified potential connections between SDOH and their impact on medication use in people with psychiatric disorders. We provide examples of how comprehensive medication management can afford opportunities for pharmacists to mitigate medication-related problems associated with SDOH.
Conclusion:
Public health officials should be aware of the vital role that pharmacists play in addressing medication therapy problems associated with SDOH to improve health outcomes and to incorporate them in health promotion programs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.